Document Detail

The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP).
MedLine Citation:
PMID:  1643015     Owner:  NLM     Status:  MEDLINE    
A detailed analysis of immunophenotype of 112 infants aged less than 18 months with acute lymphoblastic leukaemia (ALL) was performed. Patients were divided into three groups on the basis of age at presentation (under 6 months: group 1: 6-12 months: group 2; 13-18 months: group 3). There were three cases of T-ALL (2.6%). The proportion of other subtypes was: common ALL in 59 patients (52.68%), pre-B ALL in 15 patients (13.3%), pre-pre-B ALL in 27 (24.1%) and acute undifferentiated leukaemia (AUL) in eight patients (7.14%). In non-T ALL, positivity to CD10 (corresponding to C-ALL and pre-B ALL) was distributed in the three age groups as follows: 38.88% (group I) 65.38% (group II) and 86.36% (group III). Conversely, immature phenotypes (pre-pre-B and AUL) were found more often in the younger patients of groups I and II, as well as anomalous phenotypes, such as the presence of myeloid antigens (MyAg) and of CD7. Prognostic significance was evaluated as event-free survival (EFS) by statistical analysis. A better outcome in CD10-positive ALL than in CD10-negative ones (48% v. 25% of long-term survivors) was demonstrated in all infants. Similarly, EFS was significantly better in MyAg-negative than in MyAg-positive cases. These results were confirmed also when adjusting for white blood cell count. This allowed the identification of CD10-negative, MyAg-positive ALL, which were relatively more frequent in infants and had a poorer clinical outcome with the current therapies. This study stresses the prognostic relevance of the immunological study in infant leukaemias and its utility in choosing different therapeutic modalities for poor risk phenotypes.
G Basso; M C Putti; A Cantú-Rajnoldi; M Saitta; T Santostasi; N Santoro; A Lippi; A Comelli; L Felici; C Favre
Related Documents :
23470355 - Do infants really expect agents to act efficiently? a critical test of the rationality ...
539405 - Sodium excretion in relation to sodium intake and aldosterone excretion in newborn pre-...
633025 - Olfactory reflexes in the newborn infant.
5126955 - Coagulation defects in hypoxic full-term newborn infants.
2362225 - Mineral and trace element content of human transitory milk indentified with inductively...
1632445 - Segregation of three reciprocal translocations in the same family: t(3;4), t(5;10), and...
Publication Detail:
Type:  Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  British journal of haematology     Volume:  81     ISSN:  0007-1048     ISO Abbreviation:  Br. J. Haematol.     Publication Date:  1992 Jun 
Date Detail:
Created Date:  1992-09-10     Completed Date:  1992-09-10     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372544     Medline TA:  Br J Haematol     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  184-91     Citation Subset:  IM    
Department of Pediatrics, University of Padova, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antigens, CD / analysis
Cell Nucleus / immunology
Cytoplasm / immunology
HLA-DR Antigens / analysis
Immunoglobulins / analysis
Infant, Newborn
Precursor Cell Lymphoblastic Leukemia-Lymphoma / immunology*,  mortality,  therapy
Treatment Outcome
Reg. No./Substance:
0/Antigens, CD; 0/HLA-DR Antigens; 0/Immunoglobulins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A randomized study of intermediate versus conventional-dose cytarabine as intensive induction for ac...
Next Document:  Non-radioactive in situ hybridization for the detection and monitoring of trisomy 12 in B-cell chron...